CTRI/2021/12/038418尚未招募未知
TO EVALUATE THE SAFETY , EFFICACY AND PREDICTABILITY OF FEMTOSECOND LASER (LENSAR) ENABLED ARCUATE INCISIONS FOR THE CORRECTION OF PREOPERATIVE TOPOGRAPHIC ASTIGMATISM AT THE TIME OF CATARACT SURGERY
ENSAR0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •CATARACT EYES WITH NO COMORBIDITIES
- •ASTIGMATISM OF -0.75D TO -2D
- •UNILATERAL EYE
排除标准
- •CORNEAL ECTATIC CONDITIONS
- •CORNEAL SCARS
- •POST REFRACTIVE SURGERY
- •RETINAL PATHOLOGIES
研究者
相似试验
招募中
不适用
Evaluation of the safety, effectiveness and natural care approach of the Jauni phototherapy romper.icterusJaundice10019654NL-OMON56682Erasmus MC, Universitair Medisch Centrum Rotterdam12
尚未招募
2 期
Evaluation of the effect of microneedling with tranexamic acid in combination with hydroquinone formula in comparison with either alone in the treatment of melasmaChloasmaIRCT20220122053789N1Iran University of Medical Sciences50
尚未招募
3 期
Study of Tuberculosis resistant to treatmentCTRI/2021/03/032189International Union Against Tuberculosis and Lung Disease
已完成
1 期
An Open Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with Androgenetic Alopecia Treated with HMI-115 over a 24-Week Treatment PeriodAndrogenetic AlopeciaACTRN12622000680763Hope Medicine (Nanjing) Co., Ltd16
进行中（未招募）
不适用
EVALUATION OF THE EFFICACY, SAFETY AND TOLERABILITY OF THE CONCURRENT ADMINISTRATION OF CHF 4226 HFA pMDI AND EXTRAFINE BUDESONIDE HFA pMDI, BOTH GIVEN ONCE OR TWICE DAILY (2µg + 200µg qd or 1µg + 100µg bid) OVER AN 8-WEEK RANDOMIZED DOUBLE-BLIND TREATMENT PERIOD IN ADULT PATIENTS WITH MODERATE PERSISTENT ASTHMA AND PRESENTING WITH SYMPTOMS ON EXISTING INHALED CORTICOSTEROID THERAPY.Moderate persistent asthma sub optimally controlled on existing therapy.MedDRA version: 8Level: PTClassification code 10003553EUCTR2006-000038-11-HUCHIESI Farmaceutici S.p.A304